Literature DB >> 19258669

Oxytocin in the cardiovascular responses to stress.

A Wsol1, A Cudnoch-Jedrzejewska, E Szczepanska-Sadowska, S Kowalewski, L Puchalska.   

Abstract

The present study was designed to determine the role of central oxytocin (OXY) in regulation of the cardiovascular responses to the alarming stress. Three groups of male, normotensive Sprague Dawley rats, received intracerebroventricular (i.c.v.) infusion of one of the following: 1) vehicle, 2) OXY or 3) OXY antagonist (OXANT). Mean arterial blood pressure (MABP) and heart rate (HR) were recorded at rest, during and after application of the alarming stressor (air jet). Under resting conditions the i.c.v. infusions of vehicle, OXY or OXYANT did not influence the cardiovascular parameters. The alarming stressor evoked significant increases in MABP and HR that were significantly greater in the rats receiving i.c.v. infusion of oxytocin antagonist than in those receiving vehicle or OXY. The study provides evidence that stimulation of the brain oxytocin receptors by endogenous oxytocin plays significant role in inhibition of cardiovascular responses to stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19258669

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  11 in total

1.  The anorexigenic and hypertensive effects of nesfatin-1 are reversed by pretreatment with an oxytocin receptor antagonist.

Authors:  Gina L C Yosten; Willis K Samson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-03-24       Impact factor: 3.619

2.  The melanocortins, not oxytocin, mediate the anorexigenic and antidipsogenic effects of neuronostatin.

Authors:  Gina L C Yosten; Willis K Samson
Journal:  Peptides       Date:  2010-06-25       Impact factor: 3.750

3.  Plasma oxytocin is related to lower cardiovascular and sympathetic reactivity to stress.

Authors:  Karen M Grewen; Kathleen C Light
Journal:  Biol Psychol       Date:  2011-04-29       Impact factor: 3.251

Review 4.  REVIEW: Oxytocin: Crossing the bridge between basic science and pharmacotherapy.

Authors:  Cedric Viero; Izumi Shibuya; Naoki Kitamura; Alexei Verkhratsky; Hiroaki Fujihara; Akiko Katoh; Yoichi Ueta; Hans H Zingg; Alexandr Chvatal; Eva Sykova; Govindan Dayanithi
Journal:  CNS Neurosci Ther       Date:  2010-07-07       Impact factor: 5.243

5.  Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in rats.

Authors:  C Hicks; L Ramos; T Reekie; G H Misagh; R Narlawar; M Kassiou; I S McGregor
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

6.  Vasopressin and oxytocin in control of the cardiovascular system.

Authors:  Nina Japundžić-Žigon
Journal:  Curr Neuropharmacol       Date:  2013-03       Impact factor: 7.363

7.  Overexpression of oxytocin receptors in the hypothalamic PVN increases baroreceptor reflex sensitivity and buffers BP variability in conscious rats.

Authors:  Maja Lozić; Michael Greenwood; Olivera Šarenac; Andrew Martin; Charles Hindmarch; Tatjana Tasić; Julian Paton; David Murphy; Nina Japundžić-Žigon
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

8.  Dietary manipulation and social isolation alter disease progression in a murine model of coronary heart disease.

Authors:  Yumiko Nakagawa-Toyama; Songwen Zhang; Monty Krieger
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

9.  The link between stress disorders and autonomic dysfunction in muscular dystrophy.

Authors:  Rasna Sabharwal
Journal:  Front Physiol       Date:  2014-01-29       Impact factor: 4.566

10.  Behavioral and cardiorespiratory responses to bilateral microinjections of oxytocin into the central nucleus of amygdala of Wistar rats, an experimental model of compulsion.

Authors:  Érica Maria Granjeiro; Simone Saldanha Marroni; Daniel Penteado Martins Dias; Leni Gomes Heck Bonagamba; Kauê Machado Costa; Jéssica Cristina dos Santos; José Antônio Cortes Oliveira; Benedito H Machado; Norberto Garcia-Cairasco
Journal:  PLoS One       Date:  2014-07-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.